COO Tom Mitro Discusses Aerie’s Preparation for Rhopressa Launch, Updates OIS@ASCRS on Pipeline
In this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says new hires brought on to prepare for likely commercial sale of Rhopressa bring new life and energy into a company hitting its stride. He also provides to OIS@ASCRS an update on the firm’s glaucoma pipeline.
Activity